Partner Content Partner Content SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020 – S... SMi’s 22nd Annual Superbugs & Superdrugs Conference
Partner Content Partner Content SMi’s Exclusive Interview with Mark Albrecht just released SMi Reports: An exclusive interview with Biomedical Adv
Events Partner Content Superbugs & Superdrugs USA Superbugs & Superdrugs USA November 12 – 13, 2018 New Jersey, USA
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
